Cargando…

The Promising Therapeutic Potential of Celastrol for Fibrotic Diseases: A Systematic Literature Review on Its Mechanism

Celastrol is a pentacyclic tripterine sourced from Tripterygium wilfordii hook root. Celastrol can exert certain biological functions such as antitumor, anti-inflammatory, and antiproliferative properties. Celastrol was shown from the previous literature to be capable of attenuating many fibrotic di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohd Khairudin, Nurin Yasmin, Azme, Nasibah, Nasrudin, Nurdiyana, Ab Karim, Siti Aznida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523829/ https://www.ncbi.nlm.nih.gov/pubmed/37772226 http://dx.doi.org/10.7759/cureus.44269

Ejemplares similares

The need to map existing health care services for refugees in Malaysia
por: Yunus, Raudah Mohd, et al.
Publicado: (2021)

Celastrol: A Promising Agent Fighting against Cardiovascular Diseases
por: Li, Zhexi, et al.
Publicado: (2022)

Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications
por: Wagh, Pushkaraj Rajendra, et al.
Publicado: (2021)

The therapeutic potential of triptolide and celastrol in neurological diseases
por: Cui, Yueran, et al.
Publicado: (2022)

Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy
por: Pasello, Michela, et al.
Publicado: (2011)

Effects of diclofenac on the pharmacokinetics of celastrol in rats and its transport
por: Wang, Zengfu, et al.
Publicado: (2018)

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
por: Wang, Huabo, et al.
Publicado: (2015)

Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol
por: Xiao-pei, Huang, et al.
Publicado: (2018)

Correction: Systematic identification of celastrol-binding proteins reveals that Shoc2 is inhibited by celastrol
Publicado: (2021)

Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms
por: Li, Mengzhen, et al.
Publicado: (2022)

The Potential Therapeutic Role of Celastrol in Patients With Heart Failure With Preserved Ejection Fraction
por: Ajmal, Maryam, et al.
Publicado: (2021)

Inhibition of IKKβ by celastrol and its analogues – an in silico and in vitro approach
por: Veerappan, Karpagam, et al.
Publicado: (2016)

Anticariogenic Activity of Celastrol and Its Enhancement of Streptococcal Antagonism in Multispecies Biofilm
por: Li, Hao, et al.
Publicado: (2023)

Formulation and Evaluation of Celastrol-Loaded Liposomes
por: Song, Jie, et al.
Publicado: (2011)

Autophagy in the pharmacological activities of celastrol (Review)
por: Zhang, Caixia, et al.
Publicado: (2023)

The Promise of Biomarkers in Colorectal Cancer Detection
por: Umar, Asad, et al.
Publicado: (2004)

Microvascular Targets for Anti-Fibrotic Therapeutics
por: Pu, Kai-Ming T., et al.
Publicado: (2013)

Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application
por: Shi, Jinfeng, et al.
Publicado: (2020)

Induction of the ER stress response in NRVMs is linked to cardiotoxicity caused by celastrol: Celastrol cardiotoxicity involves the ER stress response
por: Chen, Zhong, et al.
Publicado: (2022)

Fabry Disease and Its Management: A Literature Analysis
por: Besekar, Smruti M, et al.
Publicado: (2023)

Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
por: Zhu, Yi, et al.
Publicado: (2022)

Quantitative Proteomics Reveals Cellular Targets of Celastrol
por: Hansen, Jakob, et al.
Publicado: (2011)

PERK in POMC neurons connects celastrol with metabolism
por: He, Zhenyan, et al.
Publicado: (2021)

Cancer Diagnosis, Risk Assessment and Prediction of Therapeutic Response by Means of DNA Methylation Markers
por: Fiegl, Heidi, et al.
Publicado: (2007)

The Therapeutic Potential of Celastrol in Central Nervous System Disorders: Highlights from In Vitro and In Vivo Approaches
por: Schiavone, Stefania, et al.
Publicado: (2021)

Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets
por: Liu, Dandan, et al.
Publicado: (2022)

Therapeutic Approach to Adult Fibrotic Lung Diseases
por: Adegunsoye, Ayodeji, et al.
Publicado: (2016)

Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
por: Dolivo, David, et al.
Publicado: (2021)

Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases
por: Chen, Yingqing, et al.
Publicado: (2021)

Promise and Challenge: Markers of Prostate Cancer Detection, Diagnosis and Prognosis
por: Troyer, D. A., et al.
Publicado: (2004)

Enhancing the Bioconversion of Azelaic Acid to Its Derivatives by Response Surface Methodology
por: Khairudin, Nurshafira, et al.
Publicado: (2018)

A Systematic Review of the Randomized Controlled Trials of Gemcabene and Its Therapeutic Uses
por: Besekar, Smruti M, et al.
Publicado: (2023)

Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment
por: Sanna, Vanna, et al.
Publicado: (2015)

Synthesis and characterisation of celastrol derivatives as potential anticancer agents
por: Zhang, Hong-Jian, et al.
Publicado: (2017)

Effect of celastrol on bone structure and mechanics in arthritic rats
por: Cascão, Rita, et al.
Publicado: (2017)

Protective effect of celastrol on myocardial ischemia–reperfusion injury
por: Li, Xiaoyan, et al.
Publicado: (2017)

Celastrol Enhances the Anti-Liver Cancer Activity of Sorafenib
por: Zhang, Rui, et al.
Publicado: (2019)

Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases
por: Cascão, Rita, et al.
Publicado: (2017)

Celastrol Self-Stabilized Nanoparticles for Effective Treatment of Melanoma
por: Li, Jinran, et al.
Publicado: (2020)

Celastrol-based nanomedicine promotes corneal allograft survival
por: Li, Zhanrong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q5a0ogfab544f7pfhc389im3kk